(Q33862449)

29 July 2017

1 reference

title

Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus (English)

1 reference

acute myocardial infarction

29 July 2017

1 reference

2

1 reference

29 July 2017

Mak KH

1

1 reference

PubMed ID

10716456

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Journal of the American College of Cardiology

29 July 2017

1 reference

29 July 2017

35

1 reference

29 July 2017

3

1 reference

29 July 2017

563-568

1 reference

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronar

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Thrombolysis in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Pati

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Role of ATP-sensitive K+ channel on ECG ST segment elevation during a bout of myocardial ischemia. A study on epicardial mapping in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Effective reperfusion for acute myocardial infarction begins with effective health policy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Significance of the Thrombolysis in Myocardial Infarction scoring system in assessing infarct-related artery reperfusion and mortality rates after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

The prognostic significance of angina pectoris preceding the occurrence of a first acute myocardial infarction in 4166 consecutive hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Direct angioplasty in acute myocardial infarction. State of the art and current controversies.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Heart glucose transport and transporters in rat heart: regulation by insulin, workload and glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Proposed metabolic vicious circle in patients with large myocardial infarcts and high plasma-free-fatty-acid concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

The sulfonylurea controversy: more questions from the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900628-2

7 January 2021

10.1016/S0735-1097(99)00628-2

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10716456